Risk factors for ANA positivity in healthy persons

Arthritis Research and Therapy

Volumn 13, Issue 2, 2011, Pages

  Li, Quan Zhen ^a   Karp, David R ^a   Quan, Jiexia ^a   Branch, Valerie K ^a   Zhou, Jinchun ^a   Lian, Yun ^a   Chong, Benjamin F ^b   Wakeland, Edward K ^a   Olsen, Nancy J ^a,c  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; AUTOANTIGEN; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; IMMUNOGLOBULIN G; INTERFERON;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BLOOD SAMPLING; CELIAC DISEASE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMAN; MALE; RHEUMATOID ARTHRITIS; RISK FACTOR; RNA ANALYSIS; SYSTEMIC LUPUS ERYTHEMATOSUS; UPREGULATION; BLOOD; CLUSTER ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; IMMUNOLOGY; SEX DIFFERENCE;

ANTIBODIES, ANTINUCLEAR; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; AUTOANTIGENS; CLUSTER ANALYSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION PROFILING; HUMANS; INTERFERON TYPE I; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; RISK FACTORS; SEX FACTORS;

EID: 79952091232     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar3271     Document Type: Article

References (31)

1. Wandstrat A, Carr-Johnson F, Branch V, Gray H, Fairhurst A, Reimold A, Karp D, Wakeland E, Olsen N. Autoantibody profiling to identify individuals at risk for systemic lupus erythematosus. J Autoimmun 2006, 27:153-160. 10.1016/j.jaut.2006.09.001, 17052888.
2. Davidson A, Diamond B. Autoimmune diseases. N Engl J Med 2001, 345:340-350. 10.1056/NEJM200108023450506, 11484692.
3. Chakravarty E, Bush T, Manzi S, Clarke A, Ward M. Prevalence of adult systemic lupus erythematosus in California and Pennsylvania in 2000: estimates obtained using hospitalization data. Arthritis Rheum 2007, 56:2092-2094. 10.1002/art.22641, 2530907, 17530651.
4. Arbuckle M, McClain M, Rubertone M, Scofield R, Dennis G, James J, Harley J. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 2003, 349:1526-1533. 10.1056/NEJMoa021933, 14561795.
5. Tan E, Cohen A, Fries J, Masi A, McShane D, Rothfield N, Schaller J, Talal N, Winchester R. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982, 25:1271-1277. 10.1002/art.1780251101, 7138600.
6. Li Q, Zhou J, Wandstrat A, Carr-Johnson F, Branch V, Karp D, Mohan C, Wakeland E, Olsen N. Protein array autoantibody profiles for insights into systemic lupus erythematosus and incomplete lupus syndromes. Clin Exp Immunol 2007, 147:60-70. 1810453, 17177964.
7. Open Source Clustering Software. , http://bonsai.ims.u-tokyo.ac.jp/~mdehoon/software/cluster/
8. Müller R, Heber B, Hashimoto T, Messer G, Müllegger R, Niedermeier A, Hertl M. Autoantibodies against desmocollins in European patients with pemphigus. Clin Exp Dermatol 2009, 34:898-903.
9. Blank M, Gisondi P, Mimouni D, Peserico A, Piaserico S, Shoenfeld Y, Reunala T, Zambruno G, Di Zenzo G, Girolomoni G. New insights into the autoantibody-mediated mechanisms of autoimmune bullous diseases and urticaria. Clin Exp Rheumatol 2006, 24:S20-25.
10. Tomimura S, Ogawa F, Iwata Y, Komura K, Hara T, Muroi E, Takenaka M, Shimizu K, Hasegawa M, Fujimoto M, Sato S. Autoantibodies against matrix metalloproteinase-1 in patients with localized scleroderma. J Dermatol Sci 2008, 52:47-54. 10.1016/j.jdermsci.2008.04.013, 18565735.
11. Polgár A, Falus A, Koó E, Ujfalussy I, Seszták M, Szuts I, Konrád K, Hodinka L, Bene E, Mészáros G, Ortutay Z, Farkas E, Paksy A, Buzás EI. Elevated levels of synovial fluid antibodies reactive with the small proteoglycans biglycan and decorin in patients with rheumatoid arthritis or other joint diseases. Rheumatology (Oxford) 2003, 42:522-527.
12. Sisó A, Ramos-Casals M, Bové A, Brito-Zerón P, Soria N, Muñoz S, Testi A, Plaza J, Sentís J, Coca A. Previous antimalarial therapy in patients diagnosed with lupus nephritis: influence on outcomes and survival. Lupus 2008, 17:281-288.
13. Meroni P, Schur P. ANA screening: an old test with new recommendations. Ann Rheum Dis 2010, 69:1420-1422. 10.1136/ard.2009.127100, 20511607.
14. Sheridan S, Pignone M, Mulrow C. Framingham-based tools to calculate the global risk of coronary heart disease: a systematic review of tools for clinicians. J Gen Intern Med 2003, 18:1039-1052. 10.1111/j.1525-1497.2003.30107.x, 1494957, 14687264.
15. Fernandez S, Lobo A, Oliveira Z, Fukumori L, Périgo A, Rivitti E. Prevalence of antinuclear autoantibodies in the serum of normal blood donors. Rev Hosp Clin Fac Med Sao Paulo 2003, 58:315-319.
16. Semchuk K, Rosenberg A, McDuffie H, Cessna A, Pahwa P, Irvine D. Antinuclear antibodies and bromoxynil exposure in a rural sample. J Toxicol Environ Health A 2007, 70:638-657. 10.1080/15287390600974593, 17365618.
17. Heinlen L, Ritterhouse L, McClain M, Keith M, Neas B, Harley J, James J. Ribosomal P autoantibodies are present before SLE onset and are directed against non-C-terminal peptides. J Mol Med 2010, 88:719-727. 10.1007/s00109-010-0618-1, 20396862.
18. Silverman G, Srikrishnan R, Germar K, Goodyear C, Andrews K, Ginzler E, Tsao B. Genetic imprinting of autoantibody repertoires in systemic lupus erythematosus patients. Clin Exp Immunol 2008, 153:102-116. 10.1111/j.1365-2249.2008.03680.x, 2432104, 18510544.
19. McGrogan A, Seaman H, Wright J, de Vries C. The incidence of autoimmune thyroid disease: a systematic review of the literature. Clin Endocrinol (Oxf) 2008, 69:687-696. 10.1111/j.1365-2265.2008.03338.x, 18673466.
20. Walsh J, Bremner A, Feddema P, Leedman P, Brown S, O'Leary P. Thyrotropin and thyroid antibodies as predictors of hypothyroidism: a 13-year, longitudinal study of a community-based cohort using current immunoassay techniques. J Clin Endocrinol Metab 2010, 95:1095-1104. 10.1210/jc.2009-1977, 20097710.
21. Vynios DH, Tsagaraki I, Grigoreas GH, Samiotaki M, Panayotou G, Kyriakopoulou D, Georgiou P, Korbakis D, Panayotou A, Nanouri K, Assouti M, Andonopoulos AP. Autoantibodies against aggrecan in systemic rheumatic diseases. Biochimie 2006, 88:767-773. 10.1016/j.biochi.2006.01.004, 16488067.
22. Tzaneva S, Volc-Platzer B, Kittler H, Hönigsmann H, Tanew A. Antinuclear antibodies in patients with polymorphic light eruption: a long-term follow-up study. Br J Dermatol 2008, 158:1050-1054. 10.1111/j.1365-2133.2008.08500.x, 18341657.
23. Schmidt E, Tony H, Bröcker E, Kneitz C. Sun-induced life-threatening lupus nephritis. Ann N Y Acad Sci 2007, 1108:35-40. 10.1196/annals.1422.004, 17893968.
24. Paradela S, Lorenzo J, Martínez-Gómez W, Yebra-Pimentel T, Valbuena L, Fonseca E. Interface dermatitis in skin lesions of Kikuchi-Fujimoto's disease: a histopathological marker of evolution into systemic lupus erythematosus?. Lupus 2008, 17:1127-1135. 10.1177/0961203308092161, 19029282.
25. Wenzel J, Tüting T. An IFN-associated cytotoxic cellular immune response against viral, self-, or tumor antigens is a common pathogenetic feature in "interface dermatitis". J Invest Dermatol 2008, 128:2392-2402. 10.1038/jid.2008.96, 18418411.
26. Olsen N, Prather H, Li Q, Burns D. Autoantibody profiles in two patients with non-autoimmune muscle disease implicate a role for gliadin autoreactivity. Neuromuscul Disord 2010, 20:188-191. 10.1016/j.nmd.2009.12.008, 2841214, 20110170.
27. Bennett L, Palucka A, Arce E, Cantrell V, Borvak J, Banchereau J, Pascual V. Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J Exp Med 2003, 197:711-723. 10.1084/jem.20021553, 2193846, 12642603.
28. Li Q, Zhou J, Lian Y, Zhang B, Branch V, Carr-Johnson F, Karp D, Mohan C, Wakeland E, Olsen N. Interferon signature gene expression is correlated with autoantibody profiles in patients with incomplete lupus syndromes. Clin Exp Immunol 2010, 159:281-291. 10.1111/j.1365-2249.2009.04057.x, 2819494, 19968664.
29. Ishii T, Onda H, Tanigawa A, Ohshima S, Fujiwara H, Mima T, Katada Y, Deguchi H, Suemura M, Miyake T, Miyatake K, Kawase I, Zhao H, Tomiyama Y, Saeki Y, Nojima H. Isolation and expression profiling of genes upregulated in the peripheral blood cells of systemic lupus erythematosus patients. DNA Res 2005, 12:429-439. 10.1093/dnares/dsi020, 16769699.
30. Silveira IG, Burlingame RW, von Mühlen CA, Bender AL, Staub HL. Anti-CCP antibodies have more diagnostic impact than rheumatoid factor (RF) in a population tested for RF. Clin Rheumatol 2007, 26:1883-1889. 10.1007/s10067-007-0601-6, 17410320.
31. GEO Accession viewer. , http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE24706